Company / Operating Cash Flow per Share
Arcus Biosciences, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$5.23
FY2025
5-year range
-$5.23 / $1.57
FY2021-FY2025
Trend
-132.2%
vs FY2024
Sector context
#202 of 212
Health Care
What the data says
Among 212 Health Care companies, Arcus Biosciences, Inc. is in the bottom 5% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-14.98 in FY2016 to $1.57 in FY2022.
Based on SEC 10-K filings.
-5.23 in FY2025.
Declined from $-4.20 to $-5.23 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 212This company -$5.23 Sector average -$14.72
▼
+64.5% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 132.2% year-over-year.
- Ranks #202 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.23 | -132.2% |
| FY2024 | -$2.25 | +46.4% |
| FY2023 | -$4.20 | -367.7% |
| FY2022 | $1.57 | +139.9% |
| FY2021 | -$3.93 | -319.9% |
| FY2020 | -$0.94 | +43.2% |
| FY2019 | -$1.65 | +47.9% |
| FY2018 | -$3.16 | +76.9% |
| FY2017 | -$13.71 | +8.5% |
| FY2016 | -$14.98 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026